{"log_id": 2379490027753543677, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0, "average": 0.995217, "min": 0.995217}, "location": {"width": 36, "top": 12, "height": 38, "left": 1145}, "words": "国"}, {"probability": {"variance": 9e-06, "average": 0.99883, "min": 0.985107}, "location": {"width": 896, "top": 130, "height": 59, "left": 167}, "words": "盐酸多柔比星急性过量可加重粘膜炎,白细胞减少和血小板减少等毒性反应。急性用药过量患者"}, {"probability": {"variance": 4e-06, "average": 0.998295, "min": 0.991956}, "location": {"width": 937, "top": 176, "height": 60, "left": 127}, "words": "出现严重骨髓抑制可采取住院、抗生素疗法、输注血小板和粒细胞等措施,粘膜炎加重可采用对症治"}, {"probability": {"variance": 3e-06, "average": 0.998702, "min": 0.994686}, "location": {"width": 175, "top": 247, "height": 36, "left": 124}, "words": "疗等措施进行治疗"}, {"probability": {"variance": 5.7e-05, "average": 0.993923, "min": 0.978234}, "location": {"width": 119, "top": 295, "height": 34, "left": 136}, "words": "【临床试验】"}, {"probability": {"variance": 4e-06, "average": 0.998119, "min": 0.992766}, "location": {"width": 421, "top": 325, "height": 45, "left": 180}, "words": "1、国外上市盐酸多柔比星脂质体的临床文献"}, {"probability": {"variance": 4e-06, "average": 0.998766, "min": 0.990746}, "location": {"width": 891, "top": 361, "height": 58, "left": 180}, "words": "最初的临床研究计划由两组非对照开放的小样本试验组成。这些研究包括相似的患者群(基本"}, {"probability": {"variance": 0.003851, "average": 0.987297, "min": 0.575193}, "location": {"width": 936, "top": 410, "height": 61, "left": 137}, "words": "上无例外全为白种男性,同性恋,平均年龄为38岁,AIDS晚期,扩展性卡波氏肉瘤,表现为CD4"}, {"probability": {"variance": 0.000166, "average": 0.995521, "min": 0.913938}, "location": {"width": 940, "top": 460, "height": 60, "left": 134}, "words": "细胞数低,临床试验组中AIDS患者多数为低危患者)。参加试验的患者在与艾滋病相关的卡波氏肉瘤"}, {"probability": {"variance": 1e-06, "average": 0.999087, "min": 0.997044}, "location": {"width": 176, "top": 536, "height": 35, "left": 136}, "words": "患者中具有代表性"}, {"probability": {"variance": 5.1e-05, "average": 0.997534, "min": 0.956575}, "location": {"width": 891, "top": 559, "height": 59, "left": 185}, "words": "有247例患者参加的第一项研究是以盐酸多柔比星脂质体进行的无对照开放的多中心试验。患"}, {"probability": {"variance": 4.9e-05, "average": 0.997077, "min": 0.954772}, "location": {"width": 941, "top": 608, "height": 62, "left": 137}, "words": "者接受的平均剂量为20mg/m2,共接受2015个治疗周期,治疗间隔为2周。临床终点包括治疗反应"}, {"probability": {"variance": 2e-06, "average": 0.998989, "min": 0.994793}, "location": {"width": 283, "top": 680, "height": 38, "left": 140}, "words": "和生活质量。该研究结果如下"}, {"probability": {"variance": 9.4e-05, "average": 0.992563, "min": 0.978874}, "location": {"width": 40, "top": 720, "height": 20, "left": 825}, "words": ".3%"}, {"probability": {"variance": 0.000504, "average": 0.98663, "min": 0.934616}, "location": {"width": 150, "top": 731, "height": 27, "left": 290}, "words": "完全缓解(CR)"}, {"probability": {"variance": 0.000662, "average": 0.980954, "min": 0.937168}, "location": {"width": 44, "top": 761, "height": 20, "left": 822}, "words": "4.4%"}, {"probability": {"variance": 6e-06, "average": 0.997354, "min": 0.993619}, "location": {"width": 145, "top": 774, "height": 28, "left": 291}, "words": "部分缓解(PR)"}, {"probability": {"variance": 7.5e-05, "average": 0.993085, "min": 0.977052}, "location": {"width": 51, "top": 803, "height": 21, "left": 815}, "words": "18.5%"}, {"probability": {"variance": 0.000817, "average": 0.982444, "min": 0.919968}, "location": {"width": 107, "top": 819, "height": 25, "left": 313}, "words": "稳定(SD)"}, {"probability": {"variance": 1e-06, "average": 0.99893, "min": 0.997756}, "location": {"width": 48, "top": 847, "height": 19, "left": 820}, "words": "0.8%"}, {"probability": {"variance": 1e-06, "average": 0.998214, "min": 0.996658}, "location": {"width": 150, "top": 860, "height": 27, "left": 292}, "words": "疾病进展(PD)"}, {"probability": {"variance": 8e-06, "average": 0.998323, "min": 0.989545}, "location": {"width": 891, "top": 883, "height": 60, "left": 195}, "words": "在进行的长期随访中,仅有部分患者接受上市推荐的用药方案,对不同用药方案的疗效反应进"}, {"probability": {"variance": 9e-06, "average": 0.99861, "min": 0.980432}, "location": {"width": 940, "top": 932, "height": 61, "left": 147}, "words": "行统计学分析,差异不显著。到目前为止,平均缓解持续时间为117天,与疼痛相关的生活质量数据"}, {"probability": {"variance": 0, "average": 0.999421, "min": 0.999089}, "location": {"width": 88, "top": 1012, "height": 27, "left": 150}, "words": "有所改善"}, {"probability": {"variance": 0.000341, "average": 0.99483, "min": 0.883633}, "location": {"width": 888, "top": 1030, "height": 60, "left": 201}, "words": "37例与艾滋病相关的卡波氏肉瘤患者参加的第二项研究是无对照开放试验。盐酸多柔比星脂质"}, {"probability": {"variance": 0.001756, "average": 0.984672, "min": 0.776049}, "location": {"width": 940, "top": 1080, "height": 61, "left": 152}, "words": "体的中位剂量为20mg/m2,3周重复一次,共进行793个治疗周期,中位累计剂量为110mg/m2,有效"}, {"probability": {"variance": 0.00123, "average": 0.979144, "min": 0.918406}, "location": {"width": 72, "top": 1161, "height": 25, "left": 155}, "words": "率如下:"}, {"probability": {"variance": 2.6e-05, "average": 0.994892, "min": 0.989823}, "location": {"width": 20, "top": 1190, "height": 21, "left": 844}, "words": "0%"}, {"probability": {"variance": 1.7e-05, "average": 0.997079, "min": 0.986883}, "location": {"width": 151, "top": 1204, "height": 28, "left": 301}, "words": "完全缓解(CR)"}, {"probability": {"variance": 1.2e-05, "average": 0.997468, "min": 0.991464}, "location": {"width": 194, "top": 1238, "height": 41, "left": 302}, "words": "部分缓解(PR)"}, {"probability": {"variance": 0.000697, "average": 0.985481, "min": 0.932753}, "location": {"width": 56, "top": 1232, "height": 22, "left": 829}, "words": "61.8%"}, {"probability": {"variance": 0.004149, "average": 0.966038, "min": 0.837251}, "location": {"width": 55, "top": 1275, "height": 23, "left": 831}, "words": "26.5%"}, {"probability": {"variance": 3.7e-05, "average": 0.996, "min": 0.983936}, "location": {"width": 97, "top": 1291, "height": 25, "left": 326}, "words": "稳定(SD"}, {"probability": {"variance": 0.000361, "average": 0.987143, "min": 0.949428}, "location": {"width": 54, "top": 1319, "height": 22, "left": 832}, "words": "11.8%"}, {"probability": {"variance": 1.6e-05, "average": 0.997509, "min": 0.987899}, "location": {"width": 139, "top": 1333, "height": 26, "left": 304}, "words": "疾病进展(PD"}, {"probability": {"variance": 1.5e-05, "average": 0.997925, "min": 0.979717}, "location": {"width": 883, "top": 1355, "height": 62, "left": 206}, "words": "中位缓解持续时间为92天。截至研究结束时,共有37例患者死亡,生存期的延长效果不显著"}, {"probability": {"variance": 0.003636, "average": 0.983134, "min": 0.628638}, "location": {"width": 871, "top": 1406, "height": 59, "left": 208}, "words": "两组研究的分析根据白血球减少症、全身性疾病(包括机会性感染)CD4(细胞数进行了调整"}, {"probability": {"variance": 0.013251, "average": 0.957805, "min": 0.465704}, "location": {"width": 940, "top": 1455, "height": 61, "left": 160}, "words": "并发现原患有粒细胞减少症的患者(ANC<200个/mm3)的整体反应率(69.3%与粒细胞基础水"}, {"probability": {"variance": 0.00015, "average": 0.994599, "min": 0.9299}, "location": {"width": 938, "top": 1505, "height": 60, "left": 163}, "words": "平高的患者相同(76.6%)。同样,全身性疾病基础水平风险高的患者(79%)与低风险的患者(68%)"}, {"probability": {"variance": 0.003664, "average": 0.986607, "min": 0.581535}, "location": {"width": 939, "top": 1556, "height": 57, "left": 164}, "words": "的治疗反应率也相似。CD4计数有关的情况是:CD4数量<50个/mm3和CD4>50个/mm3的患者"}], "language": 3}